{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T18:08:51Z","timestamp":1792951731619,"version":"4.5.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1038\/s41417-026-01053-4","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T22:45:46Z","timestamp":1783723546000},"page":"981-999","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Inhibiting CXCL12\/CXCR4 axis enhances T cell activity in gastric cancer"],"prefix":"10.1038","volume":"33","author":[{"given":"Fengyu","family":"Ling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meibiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5834-4365","authenticated-orcid":false,"given":"Shuai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3712-5443","authenticated-orcid":false,"given":"Zhao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"1053_CR1","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.3390\/biomedicines9111680","volume":"9","author":"J Wen","year":"2021","unstructured":"Wen J, Lau HC-H, Peppelenbosch M, Yu J. Gastric microbiota beyond H. pylori: an emerging critical character in gastric carcinogenesis. Biomedicines. 2021;9:1680.","journal-title":"Biomedicines"},{"key":"1053_CR2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396:635\u201348.","journal-title":"Lancet"},{"key":"1053_CR3","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3322\/caac.21657","volume":"71","author":"SS Joshi","year":"2021","unstructured":"Joshi SS, Badgwell BD. Current treatment and recent progress in gastric cancer. Cancer J Clin. 2021;71:264\u201379.","journal-title":"Cancer J Clin"},{"key":"1053_CR4","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.3390\/ijms21114012","volume":"21","author":"J Machlowska","year":"2020","unstructured":"Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies. IJMS. 2020;21:4012.","journal-title":"IJMS"},{"key":"1053_CR5","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.cgh.2019.07.045","volume":"18","author":"AP Thrift","year":"2020","unstructured":"Thrift AP, El-Serag HB. Burden of gastric cancer. Clin Gastroenterol Hepatol. 2020;18:534\u201342.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1053_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2220\/biomedres.44.81","volume":"44","author":"T Iwanaga","year":"2023","unstructured":"Iwanaga T. Anatomical basis of gastrin- and CCK-secreting cells and their functions. A review. Biomed Res. 2023;44:81\u201395.","journal-title":"Biomed Res"},{"key":"1053_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s12029-020-00518-5","volume":"52","author":"M Alipour","year":"2020","unstructured":"Alipour M. Molecular mechanism of helicobacter pylori-induced gastric cancer. J Gastrointest Cancer. 2020;52:23\u201330.","journal-title":"J Gastrointest Cancer"},{"key":"1053_CR8","doi-asserted-by":"publisher","first-page":"8800","DOI":"10.2174\/0929867328666210521213352","volume":"28","author":"W Xu","year":"2021","unstructured":"Xu W, Ding M, Wang B, Cai Y, Guo C, Yuan C. Molecular mechanism of the canonical oncogenic lncRNAMALAT1in gastric cancer. CMC. 2021;28:8800\u20139.","journal-title":"CMC"},{"key":"1053_CR9","doi-asserted-by":"publisher","unstructured":"Ren N, Liang B, Li Y. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets. Biosci Rep. 2020; 40. https:\/\/doi.org\/10.1042\/bsr20200980.","DOI":"10.1042\/bsr20200980"},{"key":"1053_CR10","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1177\/03008916211070051","volume":"108","author":"F Fang","year":"2022","unstructured":"Fang F, Zhang T, Li Q, Chen X, Jiang F, Shen X. The tumor immune-microenvironment in gastric cancer. Tumori. 2022;108:541\u201351.","journal-title":"Tumori"},{"key":"1053_CR11","doi-asserted-by":"publisher","unstructured":"Khaleel A, Alkhawaja B, Al-Qaisi TS, Alshalabi L, Tarkhan AH. Pathway analysis of smoking-induced changes in buccal mucosal gene expression. Egypt J Med Hum Genet. 2022;23. https:\/\/doi.org\/10.1186\/s43042-022-00268-y.","DOI":"10.1186\/s43042-022-00268-y"},{"key":"1053_CR12","doi-asserted-by":"publisher","unstructured":"Liu Y, Li C, Lu Y, Liu C, Yang W. Tumor microenvironment-mediated immune tolerance in development and treatment of gastric cancer. Front. Immunol. 2022;13. https:\/\/doi.org\/10.3389\/fimmu.2022.1016817.","DOI":"10.3389\/fimmu.2022.1016817"},{"key":"1053_CR13","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41575-022-00591-0","volume":"19","author":"Y Zavros","year":"2022","unstructured":"Zavros Y, Merchant JL. The immune microenvironment in gastric adenocarcinoma. Nat Rev Gastroenterol Hepatol. 2022;19:451\u201367.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1053_CR14","doi-asserted-by":"publisher","unstructured":"Tie Y, Tang F, Wei Y, Wei X. Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets. J Hematol Oncol. 2022;15. https:\/\/doi.org\/10.1186\/s13045-022-01282-8.","DOI":"10.1186\/s13045-022-01282-8"},{"key":"1053_CR15","doi-asserted-by":"publisher","first-page":"8412","DOI":"10.3390\/ijms21218412","volume":"21","author":"J Korbecki","year":"2020","unstructured":"Korbecki J, Kojder K, Simi\u0144ska D, Bohatyrewicz R, Gutowska I, Chlubek D, et al. CC Chemokines in a tumor: a review of pro-cancer and anti-cancer properties of the ligands of receptors CCR1, CCR2, CCR3, and CCR4. IJMS. 2020;21:8412.","journal-title":"IJMS"},{"key":"1053_CR16","doi-asserted-by":"publisher","unstructured":"Wang X, Cheng Y, Han X, Yan J, Wu Y, Song P et al. Functional 2D iron-based nanosheets for synergistic immunotherapy, phototherapy, and chemotherapy of tumor. Adv Healthcare Mater. 2022;11. https:\/\/doi.org\/10.1002\/adhm.202200776.","DOI":"10.1002\/adhm.202200776"},{"key":"1053_CR17","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1111\/cas.14795","volume":"112","author":"X Mao","year":"2021","unstructured":"Mao X, Yang X, Chen X, Yu S, Yu S, Zhang B, et al. Single-cell transcriptome analysis revealed the heterogeneity and microenvironment of gastrointestinal stromal tumors. Cancer Sci. 2021;112:1262\u201374.","journal-title":"Cancer Sci"},{"key":"1053_CR18","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.2174\/0929867324666170830111531","volume":"26","author":"W Zhou","year":"2019","unstructured":"Zhou W, Guo S, Liu M, Burow ME, Wang G. Targeting CXCL12\/CXCR4 Axis in Tumor Immunotherapy. CMC. 2019;26:3026\u201341.","journal-title":"CMC"},{"key":"1053_CR19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/35065016","volume":"410","author":"A M\u00fcller","year":"2001","unstructured":"M\u00fcller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001;410:50\u201356.","journal-title":"Nature"},{"key":"1053_CR20","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.semcancer.2019.12.007","volume":"65","author":"SK Daniel","year":"2020","unstructured":"Daniel SK, Seo YD, Pillarisetty VG. The CXCL12-CXCR4\/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies. Semin Cancer Biol. 2020;65:176\u201388.","journal-title":"Semin Cancer Biol"},{"key":"1053_CR21","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.7150\/jca.49707","volume":"12","author":"Y Qin","year":"2021","unstructured":"Qin Y, Wang F, Ni H, Liu Y, Yin Y, Zhou X, et al. Cancer-associated fibroblasts in gastric cancer affect malignant progression via the CXCL12-CXCR4 axis. J Cancer. 2021;12:3011\u201323.","journal-title":"J Cancer"},{"key":"1053_CR22","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.3892\/ol.2017.6389","volume":"14","author":"Y Cheng","year":"2017","unstructured":"Cheng Y, Qu J, Che X, Xu L, Song N, Ma Y, et al. CXCL12\/SDF-1\u03b1 induces migration via SRC-mediated CXCR4-EGFR cross-talk in gastric cancer cells. Oncol Lett. 2017;14:2103\u201310.","journal-title":"Oncol Lett"},{"key":"1053_CR23","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1158\/0008-5472.CAN-05-3393","volume":"66","author":"K Yasumoto","year":"2006","unstructured":"Yasumoto K, Koizumi K, Kawashima A, Saitoh Y, Arita Y, Shinohara K, et al. Role of the CXCL12\/CXCR4 axis in peritoneal carcinomatosis of gastric cancer. Cancer Res. 2006;66:2181\u20137.","journal-title":"Cancer Res"},{"key":"1053_CR24","first-page":"1117","volume":"20","author":"K Tsuboi","year":"2008","unstructured":"Tsuboi K, Kodera Y, Nakanishi H, Ito S, Mochizuki Y, Nakayama G, et al. Expression of CXCL12 and CXCR4 in pT3-stage gastric cancer does not correlate with peritoneal metastasis. Oncol Rep. 2008;20:1117\u201323.","journal-title":"Oncol Rep"},{"key":"1053_CR25","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s10120-019-01011-0","volume":"23","author":"X-Z Dong","year":"2019","unstructured":"Dong X-Z, Zhao Z-R, Hu Y, Lu Y-P, Liu P, Zhang L. LncRNA COL1A1-014 is involved in the progression of gastric cancer via regulating CXCL12-CXCR4 axis. Gastric Cancer. 2019;23:260\u201372.","journal-title":"Gastric Cancer"},{"key":"1053_CR26","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1002\/ijc.29864","volume":"138","author":"D Izumi","year":"2015","unstructured":"Izumi D, Ishimoto T, Miyake K, Sugihara H, Eto K, Sawayama H, et al. CXCL12\/CXCR4 activation by cancer-associated fibroblasts promotes integrin \u03b21 clustering and invasiveness in gastric cancer. Int J Cancer. 2015;138:1207\u201319.","journal-title":"Int J Cancer"},{"key":"1053_CR27","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1158\/0008-5472.CAN-22-1427","volume":"82","author":"E Timperi","year":"2022","unstructured":"Timperi E, Gueguen P, Molgora M, Magagna I, Kieffer Y, Lopez-Lastra S, et al. Lipid-Associated Macrophages Are Induced by Cancer-Associated Fibroblasts and Mediate Immune Suppression in Breast Cancer. Cancer Res. 2022;82:3291\u2013306.","journal-title":"Cancer Res"},{"key":"1053_CR28","doi-asserted-by":"publisher","first-page":"7371","DOI":"10.3390\/ijms22147371","volume":"22","author":"T Khare","year":"2021","unstructured":"Khare T, Bissonnette M, Khare S. CXCL12-CXCR4\/CXCR7 axis in colorectal cancer: therapeutic target in preclinical and clinical studies. IJMS. 2021;22:7371.","journal-title":"IJMS"},{"key":"1053_CR29","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.7150\/thno.52435","volume":"11","author":"X Chen","year":"2021","unstructured":"Chen X, Gao A, Zhang F, Yang Z, Wang S, Fang Y, et al. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation. Theranostics. 2021;11:3392\u2013416.","journal-title":"Theranostics"},{"key":"1053_CR30","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1158\/0008-5472.CAN-14-1301","volume":"75","author":"J Shen","year":"2015","unstructured":"Shen J, Xiao Z, Wu WKK, Wang MH, To KF, Chen Y, et al. Epigenetic silencing of miR-490-3p reactivates the chromatin remodeler SMARCD1 to promote Helicobacter pylori\u2013induced gastric carcinogenesis. Cancer Res. 2015;75:754\u201365.","journal-title":"Cancer Res"},{"key":"1053_CR31","doi-asserted-by":"publisher","first-page":"100814","DOI":"10.1016\/j.xpro.2021.100814","volume":"2","author":"K Li","year":"2021","unstructured":"Li K, Wang A, Liu H, Li B. Protocol for chemically induced murine gastric tumor model. STAR Protoc. 2021;2:100814.","journal-title":"STAR Protoc"},{"key":"1053_CR32","doi-asserted-by":"publisher","first-page":"182","DOI":"10.15430\/JCP.2016.21.3.182","volume":"21","author":"JY Lee","year":"2016","unstructured":"Lee JY, Kim N, Choi YJ, Nam RH, Choi YJ, Lee S, et al. Effect of N-methyl-N-nitrosourea on Helicobacter-induced gastric carcinogenesis in C57BL\/6 mice. J Cancer Prev. 2016;21:182\u20136.","journal-title":"J Cancer Prev"},{"key":"1053_CR33","doi-asserted-by":"publisher","first-page":"8122","DOI":"10.3390\/ijms24098122","volume":"24","author":"F Keefe","year":"2023","unstructured":"Keefe F, Monz\u00f3n-Sandoval J, Rosser AE, Webber C, Li M. Single-cell transcriptomics reveals conserved regulatory networks in human and mouse interneuron development. IJMS. 2023;24:8122.","journal-title":"IJMS"},{"key":"1053_CR34","doi-asserted-by":"publisher","first-page":"D721","DOI":"10.1093\/nar\/gky900","volume":"47","author":"X Zhang","year":"2018","unstructured":"Zhang X, Lan Y, Xu J, Quan F, Zhao E, Deng C, et al. CellMarker: a manually curated resource of cell markers in human and mouse. Nucleic Acids Res. 2018;47:D721\u2013D728.","journal-title":"Nucleic Acids Res"},{"key":"1053_CR35","doi-asserted-by":"publisher","first-page":"317","DOI":"10.14348\/molcells.2021.0211","volume":"45","author":"W Zhou","year":"2022","unstructured":"Zhou W, Wang H, Yang Y, Guo F, Yu B, Su Z. Trophoblast cell subtypes and dysfunction in the placenta of individuals with preeclampsia revealed by single-cell RNA sequencing. Mol Cells. 2022;45:317\u201328.","journal-title":"Mol Cells"},{"key":"1053_CR36","doi-asserted-by":"publisher","unstructured":"Chen S, Morine Y, Tokuda K, Yamada S, Saito Y, Nishi M et al. Cancer\u2011associated fibroblast\u2011induced M2\u2011polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor\u20111 pathway. Int J Oncol. 2021; 59. https:\/\/doi.org\/10.3892\/ijo.2021.5239.","DOI":"10.3892\/ijo.2021.5239"},{"key":"1053_CR37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.yexcr.2019.03.013","volume":"378","author":"X Li","year":"2019","unstructured":"Li X, Bu W, Meng L, Liu X, Wang S, Jiang L, et al. CXCL12\/CXCR4 pathway orchestrates CSC-like properties by CAF-recruited tumor-associated macrophage in OSCC. Exp Cell Res. 2019;378:131\u20138.","journal-title":"Exp Cell Res"},{"key":"1053_CR38","doi-asserted-by":"publisher","first-page":"937 426","DOI":"10.1080\/00365513.2016.1177660","volume":"76","author":"L Landolt","year":"2016","unstructured":"Landolt L, Marti H-P, Beisland C, Flatberg A, Eikrem OS. RNA extraction for RNA sequencing of archival renal tissues. Scand J Clin Lab Investig. 2016;76:937 426\u201334.","journal-title":"Scand J Clin Lab Investig"},{"key":"1053_CR39","doi-asserted-by":"publisher","unstructured":"Wu Z-X, Huang X, Cai M-J, Huang P-D, Guan Z. Development and validation of a prognostic index based on genes participating in autophagy in patients with lung adenocarcinoma. Front Oncol. 2022; 11. https:\/\/doi.org\/10.3389\/fonc.2021.799759.","DOI":"10.3389\/fonc.2021.799759"},{"key":"1053_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mbs.2018.08.001","volume":"304","author":"F Yuan","year":"2018","unstructured":"Yuan F, Lu L, Zhang Y, Wang S, Cai Y-D. Data mining of the cancer-related lncRNAs GO terms and KEGG pathways by using mRMR method. Math Biosci. 2018;304:1\u20138.","journal-title":"Math Biosci"},{"key":"1053_CR41","first-page":"685","volume":"37","author":"B-C Jiang","year":"2016","unstructured":"Jiang B-C, He L-N, Wu X-B, Shi H, Zhang W-W, Zhang Z-J, et al. Promoted interaction of 944\u2009C\/EBP\u03b1 with demethylatedCxcr3Gene promoter contributes to neuropathic pain in mice. J Neurosci. 2016;37:685\u2013700.","journal-title":"J Neurosci"},{"key":"1053_CR42","doi-asserted-by":"publisher","unstructured":"Fang W, Zhou T, Shi H, Yao M, Zhang D, Qian H et al. Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8\u2009+\u2009T cell exclusion. J Exp Clin Cancer Res. 2021; 40. https:\/\/doi.org\/10.1186\/s13046-020-01786-6.","DOI":"10.1186\/s13046-020-01786-6"},{"key":"1053_CR43","doi-asserted-by":"crossref","unstructured":"Liu L, Xie D, Xie H, Huang W, Zhang J, Jin W et al. ARHGAP10 Inhibits the proliferation and metastasis of CRC cells via blocking the activity of RhoA\/AKT signaling pathway. Onco Targets Ther. 2019;12: 11507\u201316.","DOI":"10.2147\/OTT.S222564"},{"key":"1053_CR44","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.1093\/rheumatology\/keac288","volume":"61","author":"S Selickaja","year":"2022","unstructured":"Selickaja S, Galindo-Feria AS, Dani L, Mimori T, R\u00f6nnelid J, Holmqvist M, et al. ELISA, 954 protein immunoprecipitation and line blot assays for anti-TIF1-gamma autoantibody detection in cancer-associated dermatomyositis. Rheumatology. 2022;61:4991\u20136.","journal-title":"Rheumatology"},{"key":"1053_CR45","doi-asserted-by":"publisher","first-page":"23169","DOI":"10.18632\/aging.203609","volume":"13","author":"S Zong","year":"2021","unstructured":"Zong S, Dai W, Guo X, Wang K. LncRNA-SNHG1 promotes macrophage M2-like polarization and contributes to breast cancer growth and metastasis. Aging. 2021;13:23169\u201381.","journal-title":"Aging"},{"key":"1053_CR46","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41423-023-01047-4","volume":"20","author":"L Jing","year":"2023","unstructured":"Jing L, An Y, Cai T, Xiang J, Li B, Guo J, et al. A subpopulation of CD146+ macrophages enhances antitumor immunity by activating the NLRP3 inflammasome. Cell Mol Immunol. 2023;20:908\u201323.","journal-title":"Cell Mol Immunol"},{"key":"1053_CR47","doi-asserted-by":"publisher","first-page":"7375","DOI":"10.1158\/1078-0432.CCR-17-1283","volume":"23","author":"Y Yin","year":"2017","unstructured":"Yin Y, Yao S, Hu Y, Feng Y, Li M, Bian Z, et al. The immune-microenvironment confers chemoresistance of colorectal cancer through macrophage-derived IL6. Clin Cancer Res. 2017;23:7375\u201387.","journal-title":"Clin Cancer Res"},{"key":"1053_CR48","doi-asserted-by":"publisher","first-page":"766","DOI":"10.21037\/atm-20-4485","volume":"8","author":"M Yang","year":"2020","unstructured":"Yang M, Chen C, Wang K, Chen Y, Xia J. Astilbin influences the progression of osteoarthritis in rats by down-regulation of PGE-2 expression via the NF-\u03baB pathway. Ann Transl Med. 2020;8:766\u2013766. 966.","journal-title":"Ann Transl Med"},{"key":"1053_CR49","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41591-020-1125-8","volume":"27","author":"R Wang","year":"2021","unstructured":"Wang R, Dang M, Harada K, Han G, Wang F, Pool Pizzi M, et al. Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma. Nat Med. 2021;27:141\u201351.","journal-title":"Nat Med"},{"key":"1053_CR50","doi-asserted-by":"publisher","first-page":"e003416","DOI":"10.1136\/jitc-2021-003416","volume":"10","author":"Y Xu","year":"2022","unstructured":"Xu Y, Zeng H, Jin K, Liu Z, Zhu Y, Xu L, et al. Immunosuppressive tumor-associated macrophages expressing interlukin-10 conferred poor prognosis and therapeutic vulnerability in patients with muscle-invasive bladder cancer. J Immunother Cancer. 2022;10:e003416.","journal-title":"J Immunother Cancer"},{"key":"1053_CR51","doi-asserted-by":"publisher","unstructured":"Chen L, Zeng S, Liu X, Tang H, Wang J, Jiang Q. Cell\u2013cell communications shape tumor microenvironment and predict clinical outcomes in clear cell renal carcinoma. J Transl Med. 2023;21. https:\/\/doi.org\/10.1186\/s12967-022-03858-x.","DOI":"10.1186\/s12967-022-03858-x"},{"key":"1053_CR52","doi-asserted-by":"publisher","first-page":"166521","DOI":"10.1016\/j.bbadis.2022.166521","volume":"1868","author":"J Wu","year":"2022","unstructured":"Wu J, Liu X, Wu J, Lou C, Zhang Q, Chen H, et al. CXCL12 derived from CD248-expressing cancer-associated fibroblasts mediates M2-polarized macrophages to promote nonsmall cell lung cancer progression. Biochim Biophys Acta (BBA) Mol Basis Dis. 2022;1868:166521.","journal-title":"Biochim Biophys Acta (BBA) Mol Basis Dis"},{"key":"1053_CR53","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ejca.2012.05.005","volume":"49","author":"UM Domanska","year":"2013","unstructured":"Domanska UM, Kruizinga RC, Nagengast WB, Timmer-Bosscha H, Huls G, de Vries EGE, et al. A review on CXCR4\/CXCL12 axis in oncology: no place to hide. Eur J Cancer. 2013;49:219\u201330.","journal-title":"Eur J Cancer"},{"key":"1053_CR54","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.critrevonc.2013.08.005","volume":"88","author":"L Lombardi","year":"2013","unstructured":"Lombardi L, Tavano F, Morelli F, Latiano TP, Di Sebastiano P, Maiello E. Chemokine receptor CXCR4: role in gastrointestinal cancer. Crit Rev Oncol\/Hematol. 2013;88:696\u2013705. 985.","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"1053_CR55","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1096\/fasebj.13.13.1699","volume":"13","author":"AJ Vila-Coro","year":"1999","unstructured":"Vila-Coro AJ, Rodr\u00edguez-Frade JM, Mart\u00edn De Ana A, Moreno-Ort\u00edz MC, Mart\u00ednez-A C, Mellado M. The chemokine SDF-1alpha triggers CXCR4 receptor dimerization and activates the 988 JAK\/STAT pathway. FASEB J. 1999;13:1699\u2013710.","journal-title":"FASEB J"},{"key":"1053_CR56","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.bbamem.2006.11.002","volume":"1768","author":"JM Busillo","year":"2007","unstructured":"Busillo JM, Benovic JL. Regulation of CXCR4 signaling. Biochim Biophys Acta (BBA) Biomembr. 2007;1768:952\u201363.","journal-title":"Biochim Biophys Acta (BBA) Biomembr"},{"key":"1053_CR57","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.7150\/ijbs.82317","volume":"19","author":"Y Yang","year":"2023","unstructured":"Yang Y, Li J, Lei W, Wang H, Ni Y, Liu Y, et al. CXCL12-CXCR4\/CXCR7 axis in cancer: from mechanisms to clinical applications. Int J Biol Sci. 2023;19:3341\u201359.","journal-title":"Int J Biol Sci"},{"key":"1053_CR58","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.4049\/jimmunol.1101421","volume":"187","author":"SC De Rosa","year":"2011","unstructured":"De Rosa SC, Thomas EP, Bui J, Huang Y, deCamp A, Morgan C, et al. HIV-DNA Priming alters T cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectable. J Immunol. 2011;187:3391\u2013401.","journal-title":"J Immunol"},{"key":"1053_CR59","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00442-010-1883-y","volume":"165","author":"E Gurarie","year":"2011","unstructured":"Gurarie E, Suutarinen J, Kojola I, Ovaskainen O. Summer movements, predation and habitat use of wolves in human modified boreal forests. Oecologia. 2011;165:891\u2013903.","journal-title":"Oecologia"},{"key":"1053_CR60","doi-asserted-by":"publisher","unstructured":"Jiang X, Wang J, Deng X, Xiong F, Ge J, Xiang B et al. Role of the tumor microenvironment in PD-L1\/PD-1-mediated tumor immune escape. Mol Cancer. 2019;18. https:\/\/doi.org\/10.1186\/s12943-018-0928-4.","DOI":"10.1186\/s12943-018-0928-4"},{"key":"1053_CR61","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature23643","volume":"549","author":"ML Burr","year":"2017","unstructured":"Burr ML, Sparbier CE, Chan Y-C, Williamson JC, Woods K, Beavis PA, et al. CMTM6 1002 maintains the expression of PD-L1 and regulates anti-tumour immunity. Nature. 2017;549:101\u20135. 1003.","journal-title":"Nature"},{"key":"1053_CR62","doi-asserted-by":"publisher","unstructured":"Petty AJ, Dai R, Lapalombella R, Baiocchi RA, Benson DM, Li Z et al. Hedgehog-induced 1005 PD-L1 on tumor-associated macrophages is critical for suppression of tumor-infiltrating CD8\u2009+\u2009T 1006 cell function. JCI Insight. 2021;6. https:\/\/doi.org\/10.1172\/jci.insight.146707.","DOI":"10.1172\/jci.insight.146707"},{"key":"1053_CR63","doi-asserted-by":"publisher","unstructured":"Wen Z-F, Liu H, Gao R, Zhou M, Ma J, Zhang Y et al. Tumor cell-released autophagosomes 1008 (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased 1009 expression of PD-L1. J. Immunother. Cancer. 2018;6. https:\/\/doi.org\/10.1186\/s40425-018-0452-5.","DOI":"10.1186\/s40425-018-0452-5"},{"key":"1053_CR64","doi-asserted-by":"publisher","unstructured":"Guo F, Kong W, Li D, Zhao G, Anwar M, Xia F et al. M2-type tumor-associated macrophages 1011 upregulated PD-L1 expression in cervical cancer via the PI3K\/AKT pathway. Eur J Med Res. 2024;29. https:\/\/doi.org\/10.1186\/s40001-024-01897-2.","DOI":"10.1186\/s40001-024-01897-2"},{"key":"1053_CR65","doi-asserted-by":"publisher","first-page":"e1494110","DOI":"10.1080\/2162402X.2018.1494110","volume":"7","author":"S Gupta","year":"2018","unstructured":"Gupta S, Jain A, Syed SN, Snodgrass RG, Pfl\u00fcger-M\u00fcller B, Leisegang MS, et al. IL-6 1014 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, 1015 STAT6 and BATF transcription factors. OncoImmunology. 2018;7:e1494110.","journal-title":"OncoImmunology"},{"key":"1053_CR66","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.2217\/fon-2021-0084","volume":"17","author":"RA de Mello","year":"2021","unstructured":"de Mello RA, Amaral GA, Neves NM, Lippo EG, Parini F, Xu S, et al. Current and potential 1017 biomarkers in gastric cancer: a critical review of the literature. Future Oncol. 2021;17:3383\u201396.","journal-title":"Future Oncol"},{"key":"1053_CR67","doi-asserted-by":"publisher","unstructured":"Zhou Z, Yang Z, Wang J, Wang Q, Zhang H, Ju X Research progress on tumor-associated 1020 macrophages in gastric cancer (Review). Oncol Rep. 2021;45. https:\/\/doi.org\/10.3892\/or.2021.7986.","DOI":"10.3892\/or.2021.7986"},{"key":"1053_CR68","doi-asserted-by":"publisher","unstructured":"Mao X, Xu J, Wang W, Liang C, Hua J, Liu J et al. Crosstalk between cancer-associated 1022 fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer. 2021;20. https:\/\/doi.org\/10.1186\/s12943-021-01428-1.","DOI":"10.1186\/s12943-021-01428-1"},{"key":"1053_CR69","doi-asserted-by":"publisher","first-page":"147446","DOI":"10.1016\/j.brainres.2021.147446","volume":"1763","author":"K Roosen","year":"2021","unstructured":"Roosen K, Scheld M, Mandzhalova M, Clarner T, Beyer C, Zendedel A. CXCL12 inhibits inflammasome activation in LPS-stimulated BV2 cells. Brain Res. 2021;1763:147446.","journal-title":"Brain Res"},{"key":"1053_CR70","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1158\/1078-0432.CCR-09-2329","volume":"16","author":"BA Teicher","year":"2010","unstructured":"Teicher BA, Fricker SP. CXCL12 (SDF-1)\/CXCR4 pathway in cancer. Clin Cancer Res. 2010;16:2927\u201331.","journal-title":"Clin Cancer Res"},{"key":"1053_CR71","doi-asserted-by":"publisher","unstructured":"Kravtsova-Ivantsiv Y, Goldhirsh G, Ciechanover A CXCL12 restricts tumor growth by suppressing the Ras, ERK1\/2, c-Myc, and the immune checkpoint PD-L1 pathways. Proc Natl Acad Sci USA. 2024;121. https:\/\/doi.org\/10.1073\/pnas.2416909121.","DOI":"10.1073\/pnas.2416909121"},{"key":"1053_CR72","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1158\/0008-5472.CAN-24-4916","volume":"86","author":"S Liu","year":"2025","unstructured":"Liu S, Zhang Z, Wang Z, Liu C, Liang G, Xu T, et al. SPP1 drives colorectal cancer liver metastasis and immunotherapy resistance by stimulating CXCL12 production in cancer-associated fibroblasts. Cancer Res. 2025;86:58\u201379.","journal-title":"Cancer Res"},{"key":"1053_CR73","doi-asserted-by":"publisher","unstructured":"Jia H, Chen X, Zhang L, Chen M. Cancer-associated fibroblasts in cancer development and therapy. J Hematol Oncol. 2025;18. https:\/\/doi.org\/10.1186\/s13045-025-01688-0.","DOI":"10.1186\/s13045-025-01688-0"},{"key":"1053_CR74","doi-asserted-by":"publisher","unstructured":"Deng C, Huo M, Chu H, Zhuang X, Deng G, Li W et al. Exosome circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p\/STAT6 axis to promote gastric cancer progression. Mol Cancer. 2024;23. https:\/\/doi.org\/10.1186\/s12943-024-01966-4.","DOI":"10.1186\/s12943-024-01966-4"},{"key":"1053_CR75","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.3390\/pharmaceutics14081541","volume":"14","author":"R Zhao","year":"2022","unstructured":"Zhao R, Liu J, Li Z, Zhang W, Wang F, Zhang B. Recent advances in CXCL12\/CXCR4 antagonists and nano-based drug delivery systems for cancer therapy. Pharmaceutics. 2022;14:1541.","journal-title":"Pharmaceutics"},{"key":"1053_CR76","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.3390\/cancers14092314","volume":"14","author":"R Mezzapelle","year":"2022","unstructured":"Mezzapelle R, Leo M, Caprioglio F, Colley LS, Lamarca A, Sabatino L, et al. CXCR4\/CXCL12 activities in the tumor microenvironment and implications for tumor immunotherapy. Cancers. 2022;14:2314.","journal-title":"Cancers"},{"key":"1053_CR77","doi-asserted-by":"publisher","first-page":"6596","DOI":"10.1096\/fj.201802067RR","volume":"33","author":"Y Zeng","year":"2019","unstructured":"Zeng Y, Li B, Liang Y, Reeves PM, Qu X, Ran C, et al. Dual blockade of CXCL12-CXCR4 and PD-1\u2013PD-L1 pathways prolongs survival of ovarian tumor\u2013bearing mice by prevention of immunosuppression in the tumor microenvironment. FASEB J. 2019;33:6596\u2013608.","journal-title":"FASEB J"},{"key":"1053_CR78","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.jconrel.2025.01.066","volume":"379","author":"S-L Cheng","year":"2025","unstructured":"Cheng S-L, Wu C-H, Tsai Y-J, Song J-S, Chen H-M, Yeh T-K, et al. CXCR4 antagonist-loaded nanoparticles reprogram the tumor microenvironment and enhance immunotherapy in hepatocellular carcinoma. J Control Release. 2025;379:967\u201381.","journal-title":"J Control Release"},{"key":"1053_CR79","doi-asserted-by":"publisher","unstructured":"Xiao S, Xu R, Yang Y, Zhao R, Xie Y, Lei X et al. Gastrointestinal stromal tumors regulate macrophage M2 polarization through the MIF\/CXCR4 axis to immune escape. Front. Immunol. 2024;15. https:\/\/doi.org\/10.3389\/fimmu.2024.1431535.","DOI":"10.3389\/fimmu.2024.1431535"},{"key":"1053_CR80","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1158\/2326-6066.CIR-15-0170","volume":"4","author":"JM Mota","year":"2016","unstructured":"Mota JM, Leite CA, Souza LE, Melo PH, Nascimento DC, de-Deus-Wagatsuma VM, et al. Post-sepsis state induces tumor-associated macrophage accumulation through CXCR4\/CXCL12 and favors tumor progression in mice. Cancer Immunol Res. 2016;4:312\u201322.","journal-title":"Cancer Immunol Res"},{"key":"1053_CR81","doi-asserted-by":"publisher","first-page":"e000308","DOI":"10.1136\/jitc-2019-000308","volume":"8","author":"M Zhang","year":"2020","unstructured":"Zhang M, Huang L, Ding G, Huang H, Cao G, Sun X, et al. Interferon gamma inhibits CXCL8\u2014CXCR2 axis mediated tumor-associated macrophages tumor trafficking and enhances anti-PD1 efficacy in pancreatic cancer. J Immunother Cancer. 2020;8:e000308.","journal-title":"J Immunother Cancer"},{"key":"1053_CR82","first-page":"100621","volume":"32","author":"MS Chabeli","year":"2022","unstructured":"Chabeli MS, Wang X, Yinghao L, Chen C, Yang C, Shou Y, et al. Similarities between wound re-epithelialization and Metastasis in ESCC and the crucial involvement of macrophages: a review. Cancer Treat Res Commun. 2022;32:100621.","journal-title":"Cancer Treat Res Commun"},{"key":"1053_CR83","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12038-024-00441-y","volume":"49","author":"G Reghu","year":"2024","unstructured":"Reghu G, Vemula PK, Bhat SG, Narayanan S. Harnessing the innate immune system by revolutionizing macrophage-mediated cancer immunotherapy. J Biosci. 2024;49:63 68.","journal-title":"J Biosci"},{"key":"1053_CR84","doi-asserted-by":"publisher","first-page":"6995","DOI":"10.3390\/ijms22136995","volume":"22","author":"AJ Boutilier","year":"2021","unstructured":"Boutilier AJ, Elsawa SF. Macrophage polarization states in the tumor microenvironment. IJMS. 2021;22:6995.","journal-title":"IJMS"},{"key":"1053_CR85","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-pathmechdis-032221-115501","volume":"17","author":"L Maiorino","year":"2022","unstructured":"Maiorino L, Da\u00dfler-Plenker J, Sun L, Egeblad M. Innate immunity and cancer pathophysiology. Annu Rev Pathol Mech Dis. 2022;17:425\u201357.","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"1053_CR86","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41586-019-1593-5","volume":"574","author":"O Demaria","year":"2019","unstructured":"Demaria O, Cornen S, Da\u00ebron M, Morel Y, Medzhitov R, Vivier E. Harnessing innate immunity in cancer therapy. Nature. 2019;574:45\u201356.","journal-title":"Nature"},{"key":"1053_CR87","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1002\/cam4.1085","volume":"6","author":"L Xue","year":"2017","unstructured":"Xue L, Mao X, Ren L, Chu X. Inhibition of CXCL12\/CXCR4 axis as a potential targeted therapy of advanced gastric carcinoma. Cancer Med. 2017;6:1424\u201336.","journal-title":"Cancer Med"},{"key":"1053_CR88","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/j.ccell.2025.06.006","volume":"43","author":"J Qian","year":"2025","unstructured":"Qian J, Ma C, Waterbury QT, Zhi X, Moon CS, Tu R, et al. A CXCR4 partial agonist improves immunotherapy by targeting immunosuppressive neutrophils and cancer-driven granulopoiesis. Cancer Cell. 2025;43:1512\u20131529.e11.","journal-title":"Cancer Cell"},{"key":"1053_CR89","doi-asserted-by":"publisher","first-page":"12890","DOI":"10.3390\/ijms241612890","volume":"24","author":"C Su","year":"2023","unstructured":"Su C, Yu R, Hong X, Zhang P, Guo Y, Cai J-C, et al. CXCR4 Expressed by tumor-infiltrating B cells in gastric cancer related to survival in the tumor microenvironment: an analysis combining single-cell RNA sequencing with bulk RNA sequencing. IJMS. 2023;24:12890.","journal-title":"IJMS"},{"key":"1053_CR90","doi-asserted-by":"publisher","unstructured":"Xu J, Ding L, Mei J, Hu Y, Kong X, Dai S et al. Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments. Sig Transduct Target Ther. 2025;10. https:\/\/doi.org\/10.1038\/s41392-025-02325-5.","DOI":"10.1038\/s41392-025-02325-5"},{"key":"1053_CR91","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41591-020-0880-x","volume":"26","author":"B Bockorny","year":"2020","unstructured":"Bockorny B, Semenisty V, Macarulla T, Borazanci E, Wolpin BM, Stemmer SM, et al. BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial. Nat Med. 2020;26:878\u201385.","journal-title":"Nat Med"},{"key":"1053_CR92","doi-asserted-by":"publisher","first-page":"620","DOI":"10.7150\/thno.60540","volume":"12","author":"X Li","year":"2022","unstructured":"Li X, Sun Z, Peng G, Xiao Y, Guo J, Wu B, et al. Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer. Theranostics. 2022;12:620\u201338.","journal-title":"Theranostics"},{"key":"1053_CR93","doi-asserted-by":"publisher","unstructured":"Gok Yavuz B, Gunaydin G, Gedik ME, Kosemehmetoglu K, Karakoc D, Ozgur F et al. Cancer-associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1+ TAMs. Sci Rep. 2019;9. https:\/\/doi.org\/10.1038\/s41598-019-39553-z.","DOI":"10.1038\/s41598-019-39553-z"},{"key":"1053_CR94","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/cam4.993","volume":"6","author":"A Zhang","year":"2017","unstructured":"Zhang A, Qian Y, Ye Z, Chen H, Xie H, Zhou L, et al. Cancer-associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma. Cancer Med. 2017;6:463\u201370.","journal-title":"Cancer Med"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01053-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01053-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01053-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T19:03:27Z","timestamp":1787339007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01053-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":94,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1053"],"URL":"https:\/\/doi.org\/10.1038\/s41417-026-01053-4","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"12 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All animal experiments were approved by the Animal Ethics Committee of Yongchuan Hospital of Chongqing Medical University.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}